DK0624196T3 - Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning. - Google Patents
Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning.Info
- Publication number
- DK0624196T3 DK0624196T3 DK93905779.0T DK93905779T DK0624196T3 DK 0624196 T3 DK0624196 T3 DK 0624196T3 DK 93905779 T DK93905779 T DK 93905779T DK 0624196 T3 DK0624196 T3 DK 0624196T3
- Authority
- DK
- Denmark
- Prior art keywords
- fibronectin
- matrix assembly
- polypeptides
- modulator
- matrix
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 8
- 108010067306 Fibronectins Proteins 0.000 title abstract 8
- 239000011159 matrix material Substances 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micromachines (AREA)
- Mechanical Light Control Or Optical Switches (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/829,462 US5453489A (en) | 1992-01-31 | 1992-01-31 | Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly |
| PCT/US1993/000909 WO1993015203A2 (en) | 1992-01-31 | 1993-02-01 | Polypeptides with fibronectin binding sites as modulators for matrix assembly |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0624196T3 true DK0624196T3 (da) | 1997-11-03 |
Family
ID=25254610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93905779.0T DK0624196T3 (da) | 1992-01-31 | 1993-02-01 | Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5453489A (da) |
| EP (1) | EP0624196B1 (da) |
| JP (1) | JPH07506342A (da) |
| AT (1) | ATE152173T1 (da) |
| AU (1) | AU672967B2 (da) |
| CA (1) | CA2129115A1 (da) |
| DE (1) | DE69310145T2 (da) |
| DK (1) | DK0624196T3 (da) |
| FI (1) | FI943568A (da) |
| NO (1) | NO942825L (da) |
| WO (1) | WO1993015203A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5492890A (en) * | 1990-12-03 | 1996-02-20 | The Scripps Research Institute | Polypeptides for promoting cell attachment |
| US5629291A (en) * | 1992-01-31 | 1997-05-13 | La Jolla Cancer Research Foundation | Methods of modulating fibronectin extracellular matrix assembly |
| US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| US5922676A (en) * | 1996-09-20 | 1999-07-13 | The Burnham Institute | Methods of inhibiting cancer by using superfibronectin |
| US6685943B1 (en) | 1997-01-21 | 2004-02-03 | The Texas A&M University System | Fibronectin binding protein compositions and methods of use |
| GB9714276D0 (en) | 1997-07-08 | 1997-09-10 | Univ Dundee | Peptides and related compounds |
| US6194378B1 (en) | 1998-02-18 | 2001-02-27 | The Research Foundation Of State University Of New York | Fibronectin peptides-based extracellular matrix for wound healing |
| US6852318B1 (en) | 1998-05-08 | 2005-02-08 | The Regents Of The University Of California | Methods for detecting and inhibiting angiogenesis |
| EP1420820A4 (en) * | 2001-07-31 | 2005-04-06 | Univ Texas | ANTIGENS AND ANTIBODIES FOR TRANSLOQUED MOLECULES OF MICROORGANISMS AND USES THEREOF |
| CA2624900A1 (en) * | 2005-10-04 | 2007-04-19 | The Research Foundation Of State University Of New York | Fibronectin polypeptides and methods of use |
| CA2690734A1 (en) * | 2007-06-14 | 2008-12-24 | Richard A. Clark | Polypeptides and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4341764A (en) * | 1980-03-05 | 1982-07-27 | Cutter Laboratories, Inc. | Method of preparing fibronectin and antihemophilic factor |
| US4589881A (en) * | 1982-08-04 | 1986-05-20 | La Jolla Cancer Research Foundation | Polypeptide |
| US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
-
1992
- 1992-01-31 US US07/829,462 patent/US5453489A/en not_active Expired - Fee Related
-
1993
- 1993-02-01 AT AT93905779T patent/ATE152173T1/de not_active IP Right Cessation
- 1993-02-01 EP EP93905779A patent/EP0624196B1/en not_active Expired - Lifetime
- 1993-02-01 WO PCT/US1993/000909 patent/WO1993015203A2/en active IP Right Grant
- 1993-02-01 JP JP5513490A patent/JPH07506342A/ja active Pending
- 1993-02-01 DK DK93905779.0T patent/DK0624196T3/da active
- 1993-02-01 AU AU36568/93A patent/AU672967B2/en not_active Ceased
- 1993-02-01 CA CA002129115A patent/CA2129115A1/en not_active Abandoned
- 1993-02-01 DE DE69310145T patent/DE69310145T2/de not_active Expired - Fee Related
-
1994
- 1994-07-29 NO NO942825A patent/NO942825L/no unknown
- 1994-07-29 FI FI943568A patent/FI943568A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO942825D0 (no) | 1994-07-29 |
| DE69310145T2 (de) | 1997-07-31 |
| EP0624196A1 (en) | 1994-11-17 |
| FI943568A0 (fi) | 1994-07-29 |
| WO1993015203A2 (en) | 1993-08-05 |
| WO1993015203A3 (en) | 1993-09-30 |
| EP0624196B1 (en) | 1997-04-23 |
| ATE152173T1 (de) | 1997-05-15 |
| DE69310145D1 (de) | 1997-05-28 |
| US5453489A (en) | 1995-09-26 |
| FI943568A (fi) | 1994-07-29 |
| AU3656893A (en) | 1993-09-01 |
| AU672967B2 (en) | 1996-10-24 |
| CA2129115A1 (en) | 1993-08-05 |
| NO942825L (no) | 1994-09-29 |
| JPH07506342A (ja) | 1995-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0624196T3 (da) | Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning. | |
| EP0723555A4 (en) | CHEMICAL PROTEINS WITH BLOCK SUPPLEMENT ACTIVATION | |
| ATE197550T1 (de) | Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff | |
| DE69535948D1 (de) | Von wd-40 abstammende peptide und ihre verwendung | |
| GR3032161T3 (en) | Amido siladiyl bridged catalyst components, methods of making and using | |
| EP0335637A3 (en) | Nerve growth factor peptides | |
| DE68915494D1 (de) | Zubereitung mit verzögerter freigabe durch verwendung von alginaten. | |
| DE59008272D1 (de) | Kraftstoffeinspritzventil. | |
| DE69015362T2 (de) | Butylgummizusammensetzungen mit verbesserter haftung an polyester. | |
| ES2107033T3 (es) | Peptidos bpc, su preparacion y su utilizacion. | |
| DK0684816T3 (da) | 5-HT2-receptorantagonister til behandling af venöse tilstande | |
| ATE110742T1 (de) | Peptid-verbindungen. | |
| DE69434783D1 (de) | Mitteldestillate-Brennstoffzusammensetzung | |
| HUP9901673A2 (hu) | A politrauma utáni többszörös szervelégtelenség megakadályozására, valamint az extracorporeális vérkeringés utáni akut szerv károsodás megakadályozására szolgáló anti-szelektin antitestek | |
| DE3889898D1 (de) | Bitumen-Zusammensetzungen. | |
| DE69409961T2 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| ATE238791T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum | |
| DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
| ATE166937T1 (de) | Schienenanordnung | |
| NO960041D0 (no) | Hemoregulatoriske penta- eller heksapeptider | |
| ES2092758T3 (es) | Nuevos polipeptidos y adns que los codifican. | |
| ES284737U (es) | Regulador de tension | |
| NO880446D0 (no) | Smaa peptider som inhiberer binding til t-4-reseptorer. | |
| FI894652A0 (fi) | Hybridom c10g7, som producerar monoklonala antikroppar mot en antigengrupp i bukspottskoertelns b-celler, vilken har en molekylmassa av 64-69 kilodalton. | |
| ATE102292T1 (de) | Klopfregelung durch verminderung der einspritzungszeit. |